177 related articles for article (PubMed ID: 27127139)
21. The multidisciplinary management of gastrointestinal cancer. Epidemiology of oesophagogastric cancer.
Lambert R; Hainaut P
Best Pract Res Clin Gastroenterol; 2007; 21(6):921-45. PubMed ID: 18070696
[TBL] [Abstract][Full Text] [Related]
22. Risk for esophageal neoplasia in Barrett's esophagus patients with mucosal changes indefinite for dysplasia.
Horvath B; Singh P; Xie H; Thota PN; Allende DS; Pai RK; Patil DT; Plesec TP; Goldblum JR; Liu X
J Gastroenterol Hepatol; 2015 Feb; 30(2):262-7. PubMed ID: 25087917
[TBL] [Abstract][Full Text] [Related]
23. Cigarette smoking and the risk of Barrett's esophagus.
Kubo A; Levin TR; Block G; Rumore G; Quesenberry CP; Buffler P; Corley DA
Cancer Causes Control; 2009 Apr; 20(3):303-11. PubMed ID: 18853262
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of Barrett's esophagus.
Cameron AJ
Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D3-4. PubMed ID: 8013779
[No Abstract] [Full Text] [Related]
25. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years.
Drewitz DJ; Sampliner RE; Garewal HS
Am J Gastroenterol; 1997 Feb; 92(2):212-5. PubMed ID: 9040193
[TBL] [Abstract][Full Text] [Related]
26. A Barrett's esophagus registry of over 1000 patients from a specialist center highlights greater risk of progression than population-based registries and high risk of low grade dysplasia.
Picardo SL; O'Brien MP; Feighery R; O'Toole D; Ravi N; O'Farrell NJ; O'Sullivan JN; Reynolds JV
Dis Esophagus; 2015; 28(2):121-6. PubMed ID: 24428806
[TBL] [Abstract][Full Text] [Related]
27. A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma.
Schneider JL; Corley DA
Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):29-39. PubMed ID: 25743454
[TBL] [Abstract][Full Text] [Related]
28. Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study.
Alexandropoulou K; van Vlymen J; Reid F; Poullis A; Kang JY
Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):15-21. PubMed ID: 23022985
[TBL] [Abstract][Full Text] [Related]
29. Risk factors in the development of esophageal adenocarcinoma.
Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
[TBL] [Abstract][Full Text] [Related]
30. Yield of Repeat Endoscopy for Barrett's Esophagus After Normal Index Endoscopy.
Rubenstein JH; Burns JA; Arasim ME; Firsht EM; Harbrecht M; Widerquist M; Evans RR; Inadomi JM; Chang JW; Hazelton WD; Hur C; Kurlander JE; Lim F; Luebeck G; Macdonald PW; Reddy CA; Saini SD; Tan SX; Waljee AK; Lansdorp-Vogelaar I
Am J Gastroenterol; 2023 Jul; 118(7):1168-1174. PubMed ID: 36716445
[TBL] [Abstract][Full Text] [Related]
31. Etiology of Barrett's metaplasia and esophageal adenocarcinoma.
Kim R; Weissfeld JL; Reynolds JC; Kuller LH
Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):369-77. PubMed ID: 9149898
[TBL] [Abstract][Full Text] [Related]
32. Population Based Time Trends in the Epidemiology and Mortality of Gastroesophageal Junction and Esophageal Adenocarcinoma.
Agarwal S; Bell MG; Dhaliwal L; Codipilly DC; Dierkhising RA; Lansing R; Gibbons EE; Leggett CL; Kisiel JB; Iyer PG
Dig Dis Sci; 2024 Jan; 69(1):246-253. PubMed ID: 37914889
[TBL] [Abstract][Full Text] [Related]
33. Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study.
Lassen A; Hallas J; de Muckadell OB
Am J Gastroenterol; 2006 Jun; 101(6):1193-9. PubMed ID: 16771936
[TBL] [Abstract][Full Text] [Related]
34. Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study.
Beales IL; Vardi I; Dearman L; Broughton T
Dis Esophagus; 2013; 26(8):838-46. PubMed ID: 22989236
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of Barrett's esophagus and esophageal adenocarcinoma in Spain. A unicentric study.
Arroyo-Martínez Q; Rodríguez-Téllez M; García-Escudero A; Brugal-Medina J; González-Cámpora R; Caunedo Álvarez Á
Rev Esp Enferm Dig; 2016 Oct; 108(10):609-617. PubMed ID: 27616661
[TBL] [Abstract][Full Text] [Related]
36. Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study.
Sikkema M; Looman CW; Steyerberg EW; Kerkhof M; Kastelein F; van Dekken H; van Vuuren AJ; Bode WA; van der Valk H; Ouwendijk RJ; Giard R; Lesterhuis W; Heinhuis R; Klinkenberg EC; Meijer GA; ter Borg F; Arends JW; Kolkman JJ; van Baarlen J; de Vries RA; Mulder AH; van Tilburg AJ; Offerhaus GJ; ten Kate FJ; Kusters JG; Kuipers EJ; Siersema PD
Am J Gastroenterol; 2011 Jul; 106(7):1231-8. PubMed ID: 21577245
[TBL] [Abstract][Full Text] [Related]
37. Incidence of adenocarcinoma among patients with Barrett's esophagus.
Hvid-Jensen F; Pedersen L; Drewes AM; Sørensen HT; Funch-Jensen P
N Engl J Med; 2011 Oct; 365(15):1375-83. PubMed ID: 21995385
[TBL] [Abstract][Full Text] [Related]
38. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
Solaymani-Dodaran M; Logan RF; West J; Card T; Coupland C
Gut; 2004 Aug; 53(8):1070-4. PubMed ID: 15247170
[TBL] [Abstract][Full Text] [Related]
39. Barrett's esophagus-related diseases remain uncommon in China.
Huang Q; Fang DC; Yu CG; Zhang J; Chen MH
J Dig Dis; 2011 Dec; 12(6):420-7. PubMed ID: 22118690
[TBL] [Abstract][Full Text] [Related]
40. The expression of 8-hydroxydeoxyguanosine in oesophageal tissues and tumours.
Räsänen JV; Sihvo EI; Ahotupa MO; Färkkilä MA; Salo JA
Eur J Surg Oncol; 2007 Dec; 33(10):1164-8. PubMed ID: 17467227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
